Participated · Seed · Feb 2026

Oska Health offers an AI-supported coaching platform that pairs certified health coaches with digital therapy tools to deliver continuous care for high-risk, multimorbid patients suffering from chronic kidney disease, diabetes, hypertension, and other long-term conditions. Through video calls, chat, and a dedicated app, coaches translate physicians’ recommendations into day-to-day actions, aiming to boost medication adherence, strengthen health literacy, and lower avoidable hospitalisations. The company’s proprietary AI augments care teams by triaging patient needs and reducing administrative workload, making personalised chronic-care support scalable. Operating for more than three years, Oska Health has demonstrated its ability to keep patients engaged between medical appointments. The newly raised capital will fund further expansion of its AI infrastructure and broaden access to its hybrid care model across Europe. Financial details beyond the recent seed round have not been disclosed.

Participated · Seed · Feb 2026

Sherpas has built an infrastructure platform that sits beneath a firm’s existing workflows, using AI to handle everything from client intake to scenario modeling and recommendation drafting. By automating these mechanics, it delivers structured, explainable insights in minutes, freeing advisors to concentrate on strategy and client relationships. The system learns from each engagement, compounding institutional knowledge to improve future recommendations. Enterprise pilots with large advisory organizations have already validated the model under compliance and operations oversight. With its new capital, Sherpas plans to deepen its decision frameworks across retirement, tax, investment, and risk planning while expanding integrations with the enterprise systems used by advisory practices. Ultimately, the company aims to give firms a scalable, consistent operating layer that improves efficiency and client experience without adding headcount.

Participated · Series A · Feb 2026

Bound, founded in 2021 by Seth Phillips and Dan Kindler, provides a software platform that automates best-practice FX hedging strategies for finance teams, running continuously in the background without the need for specialist trading expertise. The London-based company targets UK and European firms whose revenues and margins are vulnerable to sudden exchange-rate swings driven by geopolitical and policy volatility. By simplifying what has traditionally been a complex, manual process, Bound aims to protect companies ranging from fashion brands with global supply chains to venture funds deploying capital across currencies. The product set includes perpetual FX hedging tools and other risk-management features the team continues to develop. Looking ahead, Bound plans to secure regulatory authorisation within the EU and broaden its reach across continental Europe. The company reports that its platform is on track to handle nearly $2 billion in trading volume in 2025, underscoring early traction and demand for automated currency-risk solutions.

Participated · Equity · Oct 2025

Spanish startup Aunoa builds and deploys advanced conversational AI agents that blend generative and proprietary models to automate high-volume customer interactions for sectors including banking, logistics, telecom, retail and finance. The platform integrates with existing CRM and ticketing systems, handling use cases like lead capture, customer service and scheduling while emphasizing data governance and regulatory compliance. Aunoa’s solution is already active in 10 countries and supports multiple messaging channels. In 2025, the company reported €2 million in recurring turnover and has grown to a 35-person team. The new capital will help the company scale its commercial footprint across Europe and further enhance its AI capabilities.

Participated · Seed · Sep 2025

OpenHealth provides an API-driven platform that ingests raw laboratory results from any source and standardizes them into harmonized, AI-ready datasets, plus white-label visualization tools. The product is used by clinics, labs, health and wellness companies to deliver patient-friendly reports, longitudinal insights, and personalised care. The company says it is working toward building the world’s largest usable biomarker database with longitudinal data intended to improve the lives of over 100 million people. Customers include Latin America’s largest diagnostics and hospital groups, fitness and wellness companies such as Smart Fit, healthtech firms like Aware, and a growing network of longevity providers across Europe and the Americas. OpenHealth will use the new funding to accelerate expansion across Europe and to further develop its AI-powered technology for personalised prevention and care. The company is led by CEO and founder Gerrit Glass and is staffed by a European team with clinical, technical, and health system expertise. Financially, OpenHealth closed a $3M seed round and has raised $4.3M in total to date.